PROBIOTICS FOR REGULATING BLOOD GLUCOSE

The present application refers to oral compositions comprising an effective amount of a Pediococcus acidilactici strain for use in regulating blood glucose levels, as well as for the prevention and/or treatment of hyperglycemia and/or a hyperglycemia-related condition. The application also refers to...

Full description

Saved in:
Bibliographic Details
Main Authors DÍAZ CANO, Jesús V, SANZOL BAZTAN, Gregorio, BARAJAS VÉLEZ, Miguel Ángel, ENCÍO MARTÍNEZ, Ignacio José, SÁNCHEZ-VALVERDE AMATRIAIN, Ricardo, AYO MARTÍNEZ, Josune, ARAÑA CIORDIA, Miriam, SÁNCHEZ-VALVERDE AMATRIAIN, Jorge, ONECA AGURRUZA, María
Format Patent
LanguageEnglish
French
German
Published 22.05.2024
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The present application refers to oral compositions comprising an effective amount of a Pediococcus acidilactici strain for use in regulating blood glucose levels, as well as for the prevention and/or treatment of hyperglycemia and/or a hyperglycemia-related condition. The application also refers to Pediococcus acidilactici CECT 9879, Pediococcus acidilactici CECT 9889 and Pediococcus acidilactici CECT 9967, and to these strains for use as probiotics, medicaments and for regulating blood glucose levels, as well as for the prevention and/or treatment of hyperglycemia and/or a hyperglycemia-related condition.
Bibliography:Application Number: EP20230207857